Today's Top 20 Stories
  1. Mazor shareholders approve $1.6B Medtronic transaction: 4 key points

    Mazor Robotics shareholders approved its merger with Medtronic. By Laura Dyrda -
  2. Medtronic's Q2 revenue jumps 6.1%, but spine revenue is flat: 6 things to know

    Medtronic reported $7.5 billion in second quarter revenue for the 2019 fiscal year, a 6.1 percent increase over the same period last year. By Laura Dyrda -
  3. ChoiceSpine acquired by investment firm with 2 other medical device companies: 4 notes

    Investment firm Altus Capital Partners acquired ChoiceSpine, a spinal instrumentation and biologics company. By Laura Dyrda -

Are you missing out? 2019 orthopedic marketing trends

Sponsored
Learn how to get your message in front of the right patients.
  1. 4 things to know about 3D printing in MIS

    Minimally invasive spine surgeons adopted 3D-printing technology by using biomodeling to optimize preoperative planning, according to an article in Minimally Invasive Surgery. By Shayna Korol -
  2. Innovasis enters partnership to expand into biologics market: 5 insights

    Spinal device company Innovasis partnered with Stability Biologics to enter the biologics market. By Shayna Korol -
  3. Top 10 'Spine Review' articles: Nov. 12-16

    Here are the top 10 most-read articles on Becker's Spine Review from Nov. 12-16. By Shayna Korol -
  4. Stryker completes $1.4B acquisition of K2M — 3 notes

    Stryker closed its agreement to purchase K2M for $1.4 billion. By Jackie Drees -
  1. HealthPartners to cover minimally invasive SI joint fusions

    HealthPartners issued a positive coverage decision for minimally invasive sacroiliac joint fusions. By Laura Dyrda -
  2. Geisinger's new program aims to reduce opioids, enhance recovery: 4 key notes

    Danville, Pa.-based Geisinger launched ProvenRecovery, a program designed to improve pain management and healing after surgery while also reducing opioid prescriptions, according to North Central PA. By Laura Dyrda -
  3. Predictive analytics and machine learning

    This article is a portion of a book titled "Challenges, Risks and Opportunities in Today's Spine World" edited by Stephen Hochschuler, MD, Frank Phillips, MD, and Richard Fessler, MD. You can find links to the previous chapters at the end of this article. By Laura Dyrda -
  4. Dr. Frank Phillips: The 3 core organizational issues that will position orthopedic, spine practices for the future

    Frank Phillips, MD, is program director for the section of minimally invasive spine surgery at Chicago-based Midwest Orthopaedics at Rush and Rush University Medical Center's director of the spine surgery division. By Laura Dyrda -
  1. Dr. Tom Price to advise incoming Georgia Governor Brian Kemp

    Former orthopedic surgeon, member of the U.S. House of Representatives and secretary of HHS under President Donald Trump, Tom Price, MD, will now join Georgia Governor-elect Brian Kemp's transition team, according to the Washington Examiner. By Laura Dyrda -
  2. 7 important Q&As on ERAS, multimodal pain management for orthopedics and spine

    Orthopedic and spine surgery is headed to the outpatient setting. However, surgeons must ensure their patients receive high quality care to return home within 24 hours of surgery, if possible without opioids. By Laura Dyrda -
  3. How Dr. Andrew Gitkind built a multidisciplinary department that works toward a unified goal

    Andrew Gitkind, MD, vice chairman and medical director of New York City-based Montefiore Spine Center, outlines the department's recent growth and its goals for the coming year. By Laura Dyrda -
  4. How Dr. Jason Lowenstein plans to grow Atlantic Health System's Scoliosis and Spine Deformity Center in 2019

    Jason E. Lowenstein, MD, director of the Scoliosis and Spinal Deformity Center at Morristown, N.J.-based Atlantic Health System, discusses the department's goals to expand treatment options in the future. By Laura Dyrda -
  5. Drs. Ahmed Khan, Michael Raber & more: 9 spine & neurosurgeons making headlines

    Here are nine spine and neurosurgeons making headlines. By Shayna Korol -
  6. Spinal implants market to experience 5.5% CAGR by 2023: 5 notes

    The global spinal implants market is expected to grow at a 5.5 percent compound annual growth rate between 2017 and 2023, according to a Market Research Future report. By Shayna Korol -
  7. Gender does not predict MIS TLIF outcomes, study finds

    Gender is not associated with surgical outcomes after minimally invasive transforaminal lumbar interbody fusion, according to a study in Clinical Spine Surgery. By Shayna Korol -
  8. Acute pain management and the opioid crisis addressed at FDA committee meeting

    There were 63,632 American drug overdose deaths in 2016, and 66 percent involved an opioid, according to the CDC. More than 130 people die each day from opioid-related drug overdoses, according to HHS, and nearly 80 percent of heroin users report misusing prescription opioids before using heroin. By Shayna Korol -
  9. FDA warns biologics company about illegally manufacturing stem cell products: 5 insights

    The FDA warned StemGenex Biologic Laboratories about illegally marketing an unapproved stem cell product produced in a facility with significant manufacturing violations, putting patients at risk. By Shayna Korol -

Featured Whitepapers

Webinars

Top 40 Articles from the Past 6 Months